31-08-2021, 02:03 PM
Pfizer-BioNTech COVID-19 vaccine outperforms Sinovac jab in antibody study
02-Aug-2021 By Nick Taylor
The mRNA vaccine developed by Pfizer and BioNTech generates far higher levels of antibodies against the coronavirus than Sinovac’s inactivated virus prophylactic, according to a study.
HTTPS://WWW.BIOPHARMA-REPORTER.COM/ARTIC...BODY-STUDY
02-Aug-2021 By Nick Taylor
The mRNA vaccine developed by Pfizer and BioNTech generates far higher levels of antibodies against the coronavirus than Sinovac’s inactivated virus prophylactic, according to a study.
HTTPS://WWW.BIOPHARMA-REPORTER.COM/ARTIC...BODY-STUDY